RxDoctor Payments DataLook up a doctor →

Rebecca Newby, PA

Physician Assistant · Idaho Falls, IDNPI 1457685265

Payments from drug & device makers

$9,057in general payments, 2019–2025

Across 512 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$741
  • Otsuka America Pharmaceutical, Inc.$642
  • Grifols USA, LLC$559
  • Amgen$505
  • Novo Nordisk$336
  • plus $4K from 41 others

What the payments were for

  • Food & beverage$9,057100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,057 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$28,125
Medicare patients
96
Services billed
873

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide146$181,244
OzempicSemaglutide73$79,089
FarxigaDapagliflozin Propanediol54$48,110
Nurtec OdtRimegepant Sulfate17$33,031
EliquisApixaban29$31,763
CaplytaLumateperone Tosylate13$21,148
RexultiBrexpiprazole13$18,321
XareltoRivaroxaban16$15,040
Tresiba Flextouch U-200Insulin Degludec17$14,973
TrulicityDulaglutide13$14,459
MyrbetriqMirabegron18$13,194
LinzessLinaclotide20$12,263
RestasisCyclosporine11$7,353
TrintellixVortioxetine Hydrobromide12$6,795
Lisdexamfetamine Dimesylate20$5,133

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$741$195,702159 claims
Novo NordiskOzempic$336$79,08973 claims
PfizerNurtec Odt, Eliquis$189$64,79346 claims
AstraZenecaFarxiga$242$48,11054 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$127$21,14813 claims
AbbVieLinzess, Restasis$2,134$19,61631 claims
Otsuka America Pharmaceutical, Inc.Rexulti$642$18,32113 claims
Johnson & JohnsonXarelto$139$15,04016 claims
Astellas Pharma US IncMyrbetriq$159$13,19418 claims
Eisai Inc.Dayvigo$58$3,85612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →